(Q45917252)

17 December 2017

title

Proteinuria: Is the ONTARGET renal substudy actually off target? (English)

1 reference

17 December 2017

author

Giuseppe Remuzzi

series ordinal

2

1 reference

17 December 2017

Piero Ruggenenti

series ordinal

1

object named as

Piero Ruggenenti

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

17 December 2017

Nature Reviews Nephrology

published in

1 reference

17 December 2017

volume

5

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

436-437

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/nrneph.2009.109

exact match

0 references

cites work

Longitudinal studies on the rate of decline in renal function with age.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Re-examining RAS-blocking treatment regimens for abrogating progression of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Proteinuria and the risk of developing end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Role of remission clinics in the longitudinal treatment of CKD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Retarding progression of chronic renal disease: the neglected issue of residual proteinuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.109

31 March 2020

Identifiers

DOI

10.1038/NRNEPH.2009.109

1 reference

17 December 2017

Dimensions Publication ID

1025428388

0 references

1 reference

17 December 2017